With over a million cases this year, brazil intensifies efforts against dengue through vaccination and novel mosquito control techniques
In the early hours of February 6, a temporary hospital in Brasília dedicated to dengue fever patients had to close its doors momentarily due to a generator failure. This military-aided facility, powered by the Brazilian Air Force, had seen an overwhelming number of patients, far exceeding its expected capacity. In just 24 hours, 1,300 individuals sought help, double the daily anticipated number. This incident underscores the severity of Brazil’s current dengue fever crisis, with over a million cases reported in the first two months of 2024 alone.
Dengue fever, often referred to as “breakbone fever” due to its severe muscle and joint pain, has surged in Brazil, especially in the Federal District where Brasília is located. The situation has escalated quickly, with the Federal District surpassing its total 2023 case count by mid-February. Other Brazilian states are also grappling with the epidemic, prompting several cities to declare states of emergency. The rapid rise in cases has put immense pressure on Brazil’s public health system, SUS, leading to the deployment of field hospitals and dengue tents for patient triage.
Preventive measures remain traditional, focusing on mosquito control and public awareness campaigns. Strategies include fumigation to kill mosquitoes and public education on avoiding mosquito bites and breeding grounds. However, given the unprecedented outbreak scale, Brazil is exploring additional measures to combat the disease.
A significant step forward is the introduction of the Qdenga vaccine, aiming to immunize vulnerable populations against dengue. This follows the controversy of previous vaccine attempts in places like the Philippines, which had adverse outcomes. Brazil’s approach, leveraging a vaccine with reported 80% efficacy, is under careful observation.
Furthermore, Brazil is pioneering the use of Wolbachia-infected mosquitoes, a strategy developed in collaboration with the World Mosquito Program. This innovative method involves releasing mosquitoes carrying the Wolbachia bacteria, which inhibits virus replication within mosquitoes, thereby reducing dengue transmission. The upcoming launch of a mosquito biofactory in Brazil signifies a major scale-up of this initiative.
The battle against dengue in Brazil also includes novel techniques like using drones to distribute sterilized male mosquitoes, aiming to reduce the mosquito population effectively. These efforts are part of a comprehensive strategy to manage and eventually curb the dengue fever outbreak, showcasing Brazil’s proactive stance and its potential as a model for other countries facing similar challenges.
As Brazil continues to fight the spread of dengue fever, the global community watches closely. The outcomes of these interventions may offer valuable lessons in combating mosquito-borne diseases worldwide, emphasizing the importance of innovation, public health preparedness, and community engagement in disease prevention and control.
